KNSA: Kiniksa Pharmaceuticals, Ltd. Stock

by  •  • Comments Off on KNSA: Kiniksa Pharmaceuticals, Ltd. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,328.00
Enterprise Value ($M) 1,186.92
Book Value ($M) 438.84
Book Value / Share 6.19
Price / Book 3.03
NCAV ($M) 182.81
NCAV / Share 2.58
Price / NCAV 7.26

Profitability (mra)
Return on Invested Capital (ROIC) 0.02
Return on Assets (ROA) 0.02
Return on Equity (ROE) 0.02

Liquidity (mrq)
Quick Ratio 3.79
Current Ratio 4.21

Balance Sheet (mrq) ($M)
Current Assets 270.59
Assets 519.67
Liabilities 87.78
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 270.26
Operating Income -25.20
Net Income 14.08
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Increase Decrease Due To Revision In Calculated Weighted Average Shares n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 13.30
Cash from Investing -29.56
Cash from Financing 1.50

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-05 13G/A BlackRock Inc. 10.50 31.81
02-14 13G/A Fairmount Funds Management LLC 8.10 34.54
02-14 13G/A Hillhouse Capital Advisors, Ltd. 9.90 9.55
02-13 13G/A Vanguard Group Inc 8.37 -8.11
02-12 13G Rubric Capital Management LP 8.21

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-25 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 68,692 283,386 24.24
2024-04-30 220,641 218,770 100.86
2024-04-29 99,275 152,792 64.97
2024-04-26 25,686 158,803 16.17

(click for more detail)

Similar Companies
ITCI – Intra-Cellular Therapies, Inc. JAZZ – Jazz Pharmaceuticals plc
KMDA – Kamada Ltd. KPTI – Karyopharm Therapeutics Inc.
KRON – Kronos Bio, Inc.


Financial data and stock pages provided by
Fintel.io